Celadon Pharmaceuticals

Public

Celadon Pharmaceuticals is now publicly traded

The data on this page reflects Celadon Pharmaceuticals's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Mar 28, 2022

Last Round

Debt

Jun 11, 2025

Total Funding Raised

$18.54M

Company Overview

Celadon Pharmaceuticals is a pharmaceutical company that engages in the research, cultivation, manufacturing, and supply of cannabinoid-based medicines for the chronic pain market.

AI Layer

Non-AI

Keywords

cannabinoid APIsmedical cannabispharmaceutical grade cannabisEU-GMP certificationactive pharmaceutical ingredientsAPIB2B cannabis suppliercannabis pharmavertically integrated cannabiscannabis medicinescannabis cultivationhigh-THC cannabiscannabis flowercannabis oilchronic pain treatmentcannabis research

Celadon Pharmaceuticals Comparables

Compare Celadon Pharmaceuticals with similar companies based on industry and business-model similarity.

Celadon Pharmaceuticals comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Celadon Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Debt	Jun 11, 2025
Private Placement	Sep 11, 2024
Private Placement	May 10, 2024
Private Placement	Dec 12, 2023
IPO	Mar 28, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

James Short

Chief Executive Officer

Executive Team

Celadon Pharmaceuticals Investors

Notable investors and investment history

Celadon Pharmaceuticals investors
Investor	Rounds
Seneca Partners	IPO

View all Investors

Celadon Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Celadon Pharmaceuticals Filings

SEC and related filings with document metadata.

Firmographic Details

Headquarters—

Employee Range18

Year Founded2018

Last FundingJun 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.